Literature DB >> 2173501

Abnormal vitamin D3 metabolism in patients with primary Sjögren's syndrome.

K Müller1, P Oxholm, O H Sørensen, M Thymann, M Høier-Madsen, K Bendtzen.   

Abstract

Recent studies have suggested that vitamin D3 may have an immunoregulatory role in vitro. The vitamin D3 metabolism in 35 patients with primary Sjögren's syndrome was investigated by measuring blood concentrations of 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25-(OH)2D3) and 25-hydroxyvitamin D3 (25-OHD3), as well as phenotypes and blood concentrations of Gc globulin, the main vitamin D3 binding protein in the blood. 25-OHD3 concentrations were diminished, but those of 1 alpha,25-(OH)2D3 were normal. There was no significant difference between the distribution of Gc phenotypes in the patients with primary Sjögren's syndrome and normal controls. Likewise, blood concentrations of Gc globulin corresponded to normal values. Among patients with increased concentrations of IgM rheumatoid factor there was a significant negative correlation between the serum titres of IgM rheumatoid factor and 25-OHD3 concentrations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173501      PMCID: PMC1004203          DOI: 10.1136/ard.49.9.682

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  Measurement of free calcium ion in capillary blood and serum.

Authors:  N Fogh-Andersen; T F Christiansen; L Komarmy; O Siggaard-Andersen
Journal:  Clin Chem       Date:  1978-09       Impact factor: 8.327

2.  The Copenhagen criteria for Sjögren's syndrome.

Authors:  R Manthorpe; P Oxholm; J U Prause; M Schiødt
Journal:  Scand J Rheumatol Suppl       Date:  1986

3.  Correlation between concentrations of humoral antibodies and vitamin D nutritional status: a survey study.

Authors:  S H Sedrani
Journal:  Eur J Clin Nutr       Date:  1988-03       Impact factor: 4.016

Review 4.  Immunopathological features of primary Sjögren's syndrome.

Authors:  P Youinou; Y Pennec
Journal:  Clin Exp Rheumatol       Date:  1987 Apr-Jun       Impact factor: 4.473

5.  The hepatic conversion of vitamin D in alcoholics with varying degrees of liver affection.

Authors:  B Lund; O H Sorensen; M Hilden; B Lund
Journal:  Acta Med Scand       Date:  1977

6.  25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages.

Authors:  H Reichel; H P Koeffler; J E Bishop; A W Norman
Journal:  J Clin Endocrinol Metab       Date:  1987-01       Impact factor: 5.958

7.  Enzyme-linked immunosorbent assay for determination of IgM rheumatoid factor.

Authors:  M Vejtorp; M Høier-Madsen; P Halberg
Journal:  Scand J Rheumatol       Date:  1979       Impact factor: 3.641

8.  Gc (vitamin D binding protein) subtypes in rheumatoid arthritis.

Authors:  S S Papiha; B Pal
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

9.  1 alpha,25-Dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro.

Authors:  K Muller; M Svenson; K Bendtzen
Journal:  Immunol Lett       Date:  1988-04       Impact factor: 3.685

10.  Measurement of circulating 1,25-dihydroxyvitamin D in man. Changes in serum concentrations during treatment with 1 alpha-hydroxycholecalciferol.

Authors:  B Lund; B Lund; O H Sørensen
Journal:  Acta Endocrinol (Copenh)       Date:  1979-06
View more
  7 in total

1.  The association of vitamin D deficiency with tear break-up time and Schirmer testing in non-Sjögren dry eye.

Authors:  B E Kurtul; P A Özer; M S Aydinli
Journal:  Eye (Lond)       Date:  2015-06-12       Impact factor: 3.775

Review 2.  Vitamin D in systemic and organ-specific autoimmune diseases.

Authors:  Nancy Agmon-Levin; Emanuel Theodor; Ramit Maoz Segal; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

3.  Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes?

Authors:  Chiara Baldini; Andrea Delle Sedie; Nicoletta Luciano; Pasquale Pepe; Francesco Ferro; Rosaria Talarico; Chiara Tani; Marta Mosca
Journal:  Rheumatol Int       Date:  2013-10-06       Impact factor: 2.631

4.  Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus.

Authors:  K Müller; N J Kriegbaum; B Baslund; O H Sørensen; M Thymann; K Bentzen
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

Review 5.  Vitamin D deficiency as a risk factor for the development of autoantibodies in patients with ASIA and silicone breast implants: a cohort study and review of the literature.

Authors:  Maartje J L Colaris; Rene R van der Hulst; Jan Willem Cohen Tervaert
Journal:  Clin Rheumatol       Date:  2017-03-17       Impact factor: 2.980

6.  Association of High Calcitriol Serum Levels and Its Hydroxylation Efficiency Ratio with Disease Risk in SLE Patients with Vitamin D Deficiency.

Authors:  Mónica R Meza-Meza; José Francisco Muñoz-Valle; Adolfo I Ruiz-Ballesteros; Barbara Vizmanos-Lamotte; Isela Parra-Rojas; Erika Martínez-López; Edith Oregon-Romero; Yolanda Fabiola Márquez-Sandoval; Sergio Cerpa-Cruz; Ulises de la Cruz-Mosso
Journal:  J Immunol Res       Date:  2021-12-31       Impact factor: 4.818

7.  Vitamin D Levels and Associations in Indian Patients with Primary Sjögren's Syndrome.

Authors:  Pulukool Sandhya; Gowri Mahasampath; Puneet Mashru; Joseph Dian Bondu; Victoria Job; Debashish Danda
Journal:  J Clin Diagn Res       Date:  2017-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.